INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 47 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $209,000 | -99.1% | 5,397 | -99.4% | 0.02% | -96.4% |
| Q1 2016 | $24,464,000 | -54.7% | 879,969 | -12.3% | 0.42% | -48.7% |
| Q4 2015 | $53,968,000 | +36.1% | 1,003,313 | +1.3% | 0.81% | +49.6% |
| Q3 2015 | $39,655,000 | +18.0% | 990,379 | -5.8% | 0.54% | +13.9% |
| Q2 2015 | $33,595,000 | +44.1% | 1,051,479 | +7.7% | 0.48% | +38.4% |
| Q1 2015 | $23,317,000 | +88.3% | 976,419 | +39.2% | 0.34% | +96.6% |
| Q4 2014 | $12,381,000 | +28.9% | 701,419 | +0.1% | 0.18% | +23.2% |
| Q3 2014 | $9,605,000 | -18.7% | 700,556 | +0.0% | 0.14% | -22.8% |
| Q2 2014 | $11,810,000 | -7.3% | 700,479 | 0.0% | 0.18% | -10.7% |
| Q1 2014 | $12,735,000 | – | 700,479 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 359,000 | $18,790,000 | 7.62% |
| Velan Capital Investment Management LP | 150,000 | $7,851,000 | 6.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 195,000 | $10,206,000 | 4.14% |
| Vantage Consulting Group Inc | 226,670 | $11,864,000 | 3.19% |
| Vahanian & Associates Financial Planning Inc. | 71,742 | $3,755,000 | 3.03% |
| Nicholas Investment Partners, LP | 652,886 | $34,172,000 | 2.16% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $3,199,000 | 1.97% |
| Bellevue Group AG | 3,628,919 | $189,938,000 | 1.96% |
| WASATCH ADVISORS LP | 8,235,171 | $431,029,000 | 1.76% |
| Quantum Private Wealth, LLC | 77,622 | $4,062,000 | 1.54% |